114 related articles for article (PubMed ID: 24026441)
1. Bis(oxalato)dioxovanadate(V) and bis(oxalato)oxoperoxo-vanadate(V) complexes: spectroscopic characterization and biological activity.
León IE; Etcheverry SB; Parajón-Costa BS; Baran EJ
Biol Trace Elem Res; 2013 Nov; 155(2):295-300. PubMed ID: 24026441
[TBL] [Abstract][Full Text] [Related]
2. A new oxidovanadium(IV) complex of oxodiacetic acid and dppz: spectroscopic and DFT study. Antitumor action on MG-63 human osteosarcoma cell line.
León IE; Parajón-Costa BS; Franca CA; Etcheverry SB; Baran EJ
Biol Trace Elem Res; 2015 Apr; 164(2):198-204. PubMed ID: 25534289
[TBL] [Abstract][Full Text] [Related]
3. Antitumor properties of a vanadyl(IV) complex with the flavonoid chrysin [VO(chrysin)2EtOH]2 in a human osteosarcoma model: the role of oxidative stress and apoptosis.
Leon IE; Di Virgilio AL; Porro V; Muglia CI; Naso LG; Williams PA; Bollati-Fogolin M; Etcheverry SB
Dalton Trans; 2013 Sep; 42(33):11868-80. PubMed ID: 23760674
[TBL] [Abstract][Full Text] [Related]
4. Spectroscopic behavior and biological activity of K2[VO(O2)NTA].2H2O.
Arrambide G; Barrio DA; Etcheverry SB; Gambino D; Baran EJ
Biol Trace Elem Res; 2010 Aug; 136(2):241-8. PubMed ID: 19841872
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of unsymmetrical oxidovanadium complexes: DNA-binding, cleavage studies and antitumor activities.
Lu J; Guo H; Zeng X; Zhang Y; Zhao P; Jiang J; Zang L
J Inorg Biochem; 2012 Jul; 112():39-48. PubMed ID: 22546685
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, spectroscopic characterization and antiproliferative evaluation in vitro of novel Schiff bases related to benzimidazoles.
Hranjec M; Starčević K; Pavelić SK; Lučin P; Pavelić K; Karminski Zamola G
Eur J Med Chem; 2011 Jun; 46(6):2274-9. PubMed ID: 21439689
[TBL] [Abstract][Full Text] [Related]
7. The syntheses and characterizations of vanadium complexes with 1,2-dihydroxyanthraquinone and the structure-effect relationship in their in vitro anticancer activities.
Du S; Feng J; Lu X; Wang G
Dalton Trans; 2013 Jul; 42(26):9699-705. PubMed ID: 23680987
[TBL] [Abstract][Full Text] [Related]
8. DNA damage induction and antiproliferative activity of vanadium(V) oxido monoperoxido complex containing two bidentate heteroligands.
Andrezálová L; Gbelcová H; Duračková Z
J Trace Elem Med Biol; 2013 Jan; 27(1):21-6. PubMed ID: 22575540
[TBL] [Abstract][Full Text] [Related]
9. Spectroscopic characterization of an oxovanadium(IV) complex of oxodiacetic acid and o-phenanthroline. Bioactivity on osteoblast-like cells in culture.
León IE; Etcheverry SB; Parajón-Costa BS; Baran EJ
Biol Trace Elem Res; 2012 Jun; 147(1-3):403-7. PubMed ID: 22246791
[TBL] [Abstract][Full Text] [Related]
10. Peroxo heteroligand vanadates(V): synthesis, spectra-structure relationships, and stability toward decomposition.
Djordjevic C; Vuletic N; Renslo ML; Puryear BC; Alimard R
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):25-9. PubMed ID: 8927044
[TBL] [Abstract][Full Text] [Related]
11. Hydroxylamido-amino acid complexes of oxovanadium(V). Toxicological study in cell culture and in a zebrafish model.
León IE; Di Virgilio AL; Barrio DA; Arrambide G; Gambino D; Etcheverry SB
Metallomics; 2012 Dec; 4(12):1287-96. PubMed ID: 23073485
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxic activity of metallic complexes of lawsone.
Oramas-Royo S; Torrejón C; Cuadrado I; Hernández-Molina R; Hortelano S; Estévez-Braun A; de Las Heras B
Bioorg Med Chem; 2013 May; 21(9):2471-7. PubMed ID: 23545136
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic activity of new lanthanum (III) complexes of bis-coumarins.
Kostova I; Momekov G; Zaharieva M; Karaivanova M
Eur J Med Chem; 2005 Jun; 40(6):542-51. PubMed ID: 15922838
[TBL] [Abstract][Full Text] [Related]
15. [Anticancer activity of oxovanadium compounds].
Abakumova OIu; Podobed OV; Beliaeva NF; Tochilkin AI
Biomed Khim; 2013; 59(3):305-20. PubMed ID: 23987068
[TBL] [Abstract][Full Text] [Related]
16. Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives.
Vieites M; Noblía P; Torre MH; Cerecetto H; Laura Lavaggi M; Costa-Filho AJ; Azqueta A; de Cerain AL; Monge A; Parajón-Costa B; González M; Gambino D
J Inorg Biochem; 2006 Aug; 100(8):1358-67. PubMed ID: 16698084
[TBL] [Abstract][Full Text] [Related]
17. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM
Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988
[TBL] [Abstract][Full Text] [Related]
18. Bis(4-hydroxy-2H-chromen-2-one): synthesis and effects on leukemic cell lines proliferation and NF-κB regulation.
Talhi O; Schnekenburger M; Panning J; Pinto DG; Fernandes JA; Almeida Paz FA; Jacob C; Diederich M; Silva AM
Bioorg Med Chem; 2014 Jun; 22(11):3008-15. PubMed ID: 24775915
[TBL] [Abstract][Full Text] [Related]
19. Improving the bioactivity of Zn(II)-curcumin based complexes.
Pucci D; Crispini A; Sanz Mendiguchía B; Pirillo S; Ghedini M; Morelli S; De Bartolo L
Dalton Trans; 2013 Jul; 42(26):9679-87. PubMed ID: 23680928
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of decavanadate Na4Co(H2O)6V10O28.18H2O.
Zhai F; Wang X; Li D; Zhang H; Li R; Song L
Biomed Pharmacother; 2009 Jan; 63(1):51-5. PubMed ID: 18378419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
